Abeona Therapeutics (ABEO) Inventory Average (2011 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Inventory Average of $5.8 million for Q1 2026, up 11.64% quarter-over-quarter from $5.2 million in Q4 2025.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Inventory Average (2011 - 2026) Analysis & Trends
Abeona Therapeutics' Inventory Average history runs 5 years deep, the most recent figure standing at $5.8 million for Q1 2026.
- In Q1 2026, Inventory Average changed N/A year-over-year to $5.8 million; the TTM figure through Mar 2026 stood at $5.8 million (changed N/A YoY), while the FY2012 annual figure was $172500.0, changed N/A from the prior year.
- Inventory Average for Q1 2026 stood at $5.8 million, up from $5.2 million in the prior quarter.
- The five-year high for Inventory Average was $5.8 million in Q1 2026, with the low at $3.8 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 213.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 707.10 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Abeona Therapeutics | 342.29 Mn | 195.46 Mn | 7.20 Mn | 5.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.99 Mn |
| Mar 31, 2026 | 5.77 Mn |
| Dec 31, 2025 | 5.17 Mn |
| Sep 30, 2025 | 3.77 Mn |
| Mar 31, 2013 | 172,000.00 |
| Dec 31, 2012 | 215,000.00 |
| Sep 30, 2012 | 258,500.00 |
| Jun 30, 2012 | 189,000.00 |
| Mar 31, 2012 | 124,000.00 |
| Dec 31, 2011 | 171,500.00 |